Literature DB >> 16214316

Regulation of allergy by Fc receptors.

Pierre Bruhns1, Sophie Frémont, Marc Daëron.   

Abstract

The aggregation of high-affinity IgE receptors (FcepsilonRI) on mast cells and basophils has long been known as the critical event that initiates allergic reactions. Monomeric IgE was recently found to induce a variety of effects when binding to FcepsilonRI. Upregulation of FcepsilonRI only requires binding, whereas other responses require FcepsilonRI aggregation. Interestingly, FcepsilonRI aggregation has recently been understood to generate a mixture of positive and negative intracellular signals. Mast cells and basophils also express low-affinity and, under specific conditions, high-affinity IgG receptors. When co-engaging these receptors with FcepsilonRI, IgG antibodies can amplify or dampen IgE-induced mast cell activation. On the basis of these findings, it has been proposed that FcRs can be used as targets and/or tools for new therapeutic approaches to allergies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16214316     DOI: 10.1016/j.coi.2005.09.012

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  27 in total

1.  Functional expression of IgG-Fc receptors in human airway smooth muscle cells.

Authors:  YuXiu C Xia; Michael Schuliga; Malcolm Shepherd; Maree Powell; Trudi Harris; Shenna Y Langenbach; Peck Szee Tan; William T Gerthoffer; P Mark Hogarth; Alastair G Stewart; Graham A Mackay
Journal:  Am J Respir Cell Mol Biol       Date:  2010-07-01       Impact factor: 6.914

2.  Delayed clinical and ex vivo response to mammalian meat in patients with IgE to galactose-alpha-1,3-galactose.

Authors:  Scott P Commins; Hayley R James; Whitney Stevens; Shawna L Pochan; Michael H Land; Carol King; Susan Mozzicato; Thomas A E Platts-Mills
Journal:  J Allergy Clin Immunol       Date:  2014-03-20       Impact factor: 10.793

3.  IgG subclasses determine pathways of anaphylaxis in mice.

Authors:  Héloïse Beutier; Caitlin M Gillis; Bruno Iannascoli; Ophélie Godon; Patrick England; Riccardo Sibilano; Laurent L Reber; Stephen J Galli; Mark S Cragg; Nico Van Rooijen; David A Mancardi; Pierre Bruhns; Friederike Jönsson
Journal:  J Allergy Clin Immunol       Date:  2016-04-26       Impact factor: 10.793

Review 4.  Immunotherapy in allergy and cellular tests: state of art.

Authors:  Salvatore Chirumbolo
Journal:  Hum Vaccin Immunother       Date:  2014-05-02       Impact factor: 3.452

5.  Micropatterned ligand arrays to study spatial regulation in Fc receptor signaling.

Authors:  Alexis J Torres; David Holowka; Barbara A Baird
Journal:  Methods Mol Biol       Date:  2011

Review 6.  The tyrosine kinase network regulating mast cell activation.

Authors:  Alasdair M Gilfillan; Juan Rivera
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

Review 7.  Adapters in the organization of mast cell signaling.

Authors:  Damiana Alvarez-Errico; Eva Lessmann; Juan Rivera
Journal:  Immunol Rev       Date:  2009-11       Impact factor: 12.988

8.  Protection against the allergic airway inflammation depends on the modulation of spleen dendritic cell function and induction of regulatory T cells in mice.

Authors:  Yaoli Wang; Chunxue Bai; Guansong Wang; Diane Wang; Xiaoming Cheng; Jian Huang; Dongpo Jiang; Guisheng Qian; Xiangdong Wang
Journal:  Genet Vaccines Ther       Date:  2010-03-24

9.  Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy.

Authors:  Nicole Schmitz; Klaus Dietmeier; Monika Bauer; Melanie Maudrich; Stefan Utzinger; Simone Muntwiler; Philippe Saudan; Martin F Bachmann
Journal:  J Exp Med       Date:  2009-08-10       Impact factor: 14.307

10.  Interrogation of sphingosine-1-phosphate receptor 2 function in vivo reveals a prominent role in the recovery from IgE and IgG-mediated anaphylaxis with minimal effect on its onset.

Authors:  Ana Olivera; Sandra E Dillahunt; Juan Rivera
Journal:  Immunol Lett       Date:  2013-01-18       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.